1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with cromolyn sodium in 25 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (cromolyn sodium) | Trials (cromolyn sodium) | Recent Studies (post-2010) (cromolyn sodium) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 4,204 | 898 | 246 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 13 (52.00) | 18.7374 |
1990's | 11 (44.00) | 18.2507 |
2000's | 1 (4.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iwamoto, I; Takatsu, K; Tomioka, H; Tomoe, S; Yoshida, S | 1 |
Iwamoto, I; Matsumura, R; Nakajima, H; Takatsu, K; Tomioka, H; Tomoe, S; Yoshida, S | 1 |
Yano, S | 1 |
Iwama, T; Koda, A; Nagai, H; Suda, H | 1 |
Chand, N; Diamantis, W; Nolan, K; Pillar, J; Sofia, RD | 1 |
Ishihara, K; Kuriyama, M; Matsumura, Y; Miyamoto, T; Nakamura, T | 1 |
Imanishi, N; Morooka, S; Sugasawa, T | 1 |
Arnoux, B; Benveniste, J; Devillier, P; Lalau Keraly, C; Landes, A; Marsac, J | 1 |
Befus, AD; Bienenstock, J; Lee, TD; Swieter, M | 1 |
Coutts, S; Jones, H; Khandwala, A; Neiss, E; Pruss, T; Weinryb, I | 1 |
Bruijnzeel, PL; Hamelink, ML; Kok, PT; Kreukniet, J; Warringa, RA | 1 |
Bruijnzeel, PL; Kok, PT; Warringa, RA | 1 |
Arnoux, B; Benveniste, J; Denjean, A | 1 |
Mazzoni, L; Morley, J; Page, CP; Sanjar, S | 1 |
Morley, J | 1 |
Archer, CB; MacDonald, DM; Morley, J; Page, CP; Paul, W | 1 |
Morley, J; Page, CP; Sanjar, S | 2 |
Chang, J; Dervinis, A; Lewis, AJ | 1 |
Karlsson, G; Pipkorn, U | 1 |
Basran, GS; Morley, J; Page, CP; Paul, W | 1 |
Kanwar, S; Kubes, P | 1 |
DurĂ¡n, WN; Fallek, SR; Hobson, RW; Noel, AA | 1 |
Nagai, A; Takeda, Y; Tamaoki, J; Yamawaki, I | 1 |
Feldman, MJ; Kieffer, CA; Miller, DV; Morris, GP; Paterson, WG | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cromolyn sodium
Article | Year |
---|---|
Heterogeneity in mast cell populations.
Topics: Animals; Cell Differentiation; Chemotactic Factors; Chemotaxis, Leukocyte; Chromones; Cromolyn Sodium; Cytoplasmic Granules; Exocytosis; Histamine; Histamine Release; Humans; Hypersensitivity; Intestinal Mucosa; Lung; Mast Cells; Organoids; Peptide Hydrolases; Peritoneal Cavity; Platelet Activating Factor; Proteoglycans; Skin; Species Specificity | 1985 |
Platelet activating factor and asthma.
Topics: Animals; Asthma; Cromolyn Sodium; Eosinophils; Humans; Mast Cells; Platelet Activating Factor | 1986 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cromolyn sodium
Article | Year |
---|---|
Effect of disodium chromoglycate on changes in nasal airway resistance induced by platelet activating factor.
Topics: Adult; Airway Resistance; Cromolyn Sodium; Female; Humans; Male; Platelet Activating Factor | 1984 |
22 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and cromolyn sodium
Article | Year |
---|---|
Role of CD4+ T lymphocytes and interleukin-5 in antigen-induced eosinophil recruitment into the site of cutaneous late-phase reaction in mice.
Topics: Animals; CD4-Positive T-Lymphocytes; Cell Degranulation; Cell Movement; Cromolyn Sodium; Eosinophils; Hypersensitivity; Interleukin-5; Lymphocyte Depletion; Mast Cells; Mice; Mice, Inbred BALB C; Platelet Activating Factor; Skin; Time Factors | 1992 |
CD4+ T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea.
Topics: Administration, Inhalation; Animals; Antibodies, Monoclonal; CD4-Positive T-Lymphocytes; Cromolyn Sodium; Eosinophils; Evaluation Studies as Topic; Hypersensitivity, Delayed; Injections, Intraperitoneal; Interleukin-5; Mice; Mice, Inbred BALB C; Ovalbumin; Platelet Activating Factor; Pyridinium Compounds; T-Lymphocytes, Regulatory; Trachea | 1992 |
[Drug therapy of asthma by antiallergic agents].
Topics: Asthma; Cromolyn Sodium; Histamine Antagonists; Humans; Ketotifen; ortho-Aminobenzoates; Phthalazines; Platelet Activating Factor; SRS-A | 1992 |
Effects of NZ-107 on bronchoconstriction in guinea pigs.
Topics: Albuterol; Animals; Asthma; Bronchoconstriction; Cromolyn Sodium; Disease Models, Animal; Guinea Pigs; Histamine; Hydrocortisone; Male; Metyrapone; Platelet Activating Factor; Prednisolone; Pyridazines; Respiration; Time Factors | 1992 |
Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086.
Topics: Animals; Azepines; Bronchi; Cromolyn Sodium; Guinea Pigs; Histamine Release; In Vitro Techniques; Leukocytes; Male; Muscle, Smooth; Platelet Activating Factor; Rabbits; Triazines; Triazoles | 1990 |
Platelet-activating factor (PAF) in allergic diseases: inhibitory effects of anti-allergic drugs, ketotifen and three kampo medicines on PAF production.
Topics: Adult; Cromolyn Sodium; Histamine H1 Antagonists; Humans; Hypersensitivity; Ketotifen; Male; Medicine, Chinese Traditional; Neutrophils; ortho-Aminobenzoates; Platelet Activating Factor; Pollen; Reference Values | 1991 |
Effect of the selective PAF antagonist SM-10661 on an asthmatic model. 2. Effect on antigen-induced dual asthmatic response and infiltration of leukocytes into airways in actively sensitized conscious guinea pigs.
Topics: Animals; Antigens; Asthma; Cromolyn Sodium; Disease Models, Animal; Fenoterol; Guinea Pigs; Leukocytes; Lung; Male; Ovalbumin; Platelet Activating Factor; Respiratory Function Tests; Respiratory System; Thiazoles; Thiazolidines | 1991 |
Inhibition of human and rabbit platelet activation by Ketotifen.
Topics: Adenosine Triphosphate; Animals; Blood Platelets; Cromolyn Sodium; Humans; In Vitro Techniques; Ketotifen; Platelet Activating Factor; Platelet Activation; Platelet Aggregation Inhibitors; Rabbits | 1990 |
REV 2871 (CHBZ): a potent antiallergic agent with a novel mechanism of action. I. Activity profile as an inhibitor of mediator release.
Topics: Animals; Antigens; Basophils; Calcimycin; Chromones; Cromolyn Sodium; Dextrans; Drug Synergism; Guinea Pigs; Histamine H1 Antagonists; Histamine Release; Humans; Immunoglobulin E; In Vitro Techniques; Lung; Mast Cells; Oxazoles; p-Methoxy-N-methylphenethylamine; Phosphatidylserines; Platelet Activating Factor; Rats; Tachyphylaxis; Time Factors | 1987 |
Inhibitory effects of nedocromil sodium on the in vitro induced migration and leukotriene formation of human granulocytes.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcimycin; Chemotaxis, Leukocyte; Cromolyn Sodium; Diterpenes; Eosinophils; Ginkgolides; Granulocytes; Humans; In Vitro Techniques; Lactones; Leukotriene B4; Leukotrienes; Nedocromil; Neutrophils; Platelet Activating Factor; Quinolones; SRS-A; Zymosan | 1989 |
Inhibition of platelet-activating factor- and zymosan-activated serum-induced chemotaxis of human neutrophils by nedocromil sodium, BN 52021 and sodium cromoglycate.
Topics: Calcium; Chemotaxis, Leukocyte; Cromolyn Sodium; Diterpenes; Ginkgolides; Granulocytes; Humans; In Vitro Techniques; Lactones; Nedocromil; Neutrophils; Platelet Activating Factor; Quinolones; Zymosan | 1989 |
Effect of PAF-acether in non-human primates.
Topics: Airway Resistance; Animals; Asthma; Bronchial Spasm; Constriction, Pathologic; Cromolyn Sodium; Ketotifen; Lung Compliance; Lung Volume Measurements; Nedocromil; Papio; Platelet Activating Factor; Quinolines | 1988 |
Effects of ketotifen upon responses to platelet activating factor: a basis for asthma prophylaxis.
Topics: Albuterol; Asthma; Cromolyn Sodium; Humans; Hypersensitivity; Injections, Intravenous; Ketotifen; Lung; Mast Cells; Platelet Activating Factor; Platelet Aggregation; Theophylline; Time Factors | 1986 |
Actions of disodium cromoglycate (DSCG) on human skin responses to histamine, codeine and Paf-acether.
Topics: Adult; Asthma; Codeine; Cromolyn Sodium; Histamine; Humans; Mast Cells; Platelet Activating Factor; Skin | 1985 |
Pharmacology of the late response to allergen and its relevance to asthma prophylaxis.
Topics: Airway Resistance; Allergens; Asthma; Blood Platelets; Cromolyn Sodium; Humans; Immunoglobulin E; Mast Cells; Platelet Activating Factor; Pollen; Time Factors | 1985 |
The platelet in asthma.
Topics: Airway Resistance; Asthma; Blood Platelets; Bronchial Spasm; Cromolyn Sodium; Humans; Lung; Muscle, Smooth; Platelet Activating Factor; Time Factors | 1984 |
The effects of antiallergic and bronchodilator drugs on platelet-activating factor (PAF-acether) induced bronchospasm and platelet aggregation.
Topics: Animals; Bronchial Spasm; Bronchodilator Agents; Chromones; Cromolyn Sodium; Guinea Pigs; Histamine H1 Antagonists; Male; Platelet Activating Factor; Platelet Aggregation; Promethazine; Rabbits | 1984 |
Cromoglycate (DSCG) inhibits responses to platelet-activating factor (PAF-acether) in man: an alternative mode of action for DSCG in asthma?
Topics: Adult; Asthma; Cromolyn Sodium; Humans; Mast Cells; Platelet Activating Factor | 1982 |
Histamine induces leukocyte rolling in post-capillary venules. A P-selectin-mediated event.
Topics: Animals; Antigens, CD; CD18 Antigens; Cell Adhesion; Cromolyn Sodium; Histamine; Inflammation; Leukocytes; Male; Mast Cells; P-Selectin; Platelet Activating Factor; Platelet Membrane Glycoproteins; Rats; Rats, Sprague-Dawley; Receptors, Histamine H1; Time Factors; Venules | 1994 |
Inhibition of nitric oxide synthase attenuates primed microvascular permeability in the in vivo microcirculation.
Topics: Animals; Arginine; Capillary Permeability; Cheek; Cricetinae; Cromolyn Sodium; Dextrans; Enzyme Inhibitors; Fluorescein-5-isothiocyanate; Histamine; Inflammation; Macrophage-1 Antigen; Male; Mast Cells; Mesocricetus; Microcirculation; Microscopy, Video; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Platelet Activating Factor | 1995 |
Inhaled cromoglycate reduces airway neurogenic inflammation via tachykinin antagonism.
Topics: Administration, Inhalation; Animals; Anti-Asthmatic Agents; Capillary Permeability; Cromolyn Sodium; Dose-Response Relationship, Drug; Inflammation; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Saline Solution, Hypertonic; Specific Pathogen-Free Organisms; Substance P; Tachykinins; Trachea | 1997 |
Role of platelet-activating factor in acid-induced esophageal mucosal injury.
Topics: Animals; Cromolyn Sodium; Esophagitis, Peptic; Gastroesophageal Reflux; Mast Cells; Opossums; Platelet Activating Factor; Platelet Aggregation Inhibitors; Pyridinium Compounds; Tetrahydroisoquinolines; Thioxanthenes; Xanthones | 2007 |